Wang J, Yuan M, Zhu G, Wu R, Jia C, Wang B
Int J Med Sci. 2022; 19(5):821-828.
PMID: 35693743
PMC: 9149648.
DOI: 10.7150/ijms.70146.
Spadea M, Saglio F, Tripodi S, Menconi M, Zecca M, Fagioli F
Transplant Direct. 2021; 7(11):e774.
PMID: 34646937
PMC: 8500617.
DOI: 10.1097/TXD.0000000000001226.
de Koning C, Tao W, Lacna A, van Veghel K, Horwitz M, Sanz G
Bone Marrow Transplant. 2021; 56(11):2826-2833.
PMID: 34312498
PMC: 8563413.
DOI: 10.1038/s41409-021-01417-4.
Dekker L, de Koning C, Lindemans C, Nierkens S
Cancers (Basel). 2020; 12(7).
PMID: 32698396
PMC: 7409323.
DOI: 10.3390/cancers12071974.
Naik S, Vasileiou S, Aguayo-Hiraldo P, Mukhi S, Sasa G, Martinez C
Biol Blood Marrow Transplant. 2020; 26(5):911-919.
PMID: 31927102
DOI: 10.1016/j.bbmt.2020.01.005.
Joint Modeling of Immune Reconstitution Post Haploidentical Stem Cell Transplantation in Pediatric Patients With Acute Leukemia Comparing CD34-Selected to CD3/CD19-Depleted Grafts in a Retrospective Multicenter Study.
Salzmann-Manrique E, Bremm M, Huenecke S, Stech M, Orth A, Eyrich M
Front Immunol. 2018; 9:1841.
PMID: 30154788
PMC: 6102342.
DOI: 10.3389/fimmu.2018.01841.
Low T-Cell Responses to Mitogen Stimulation Predicts Poor Survival in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.
Yong M, Cameron P, Slavin M, Cheng A, Morrissey C, Bergin K
Front Immunol. 2017; 8:1506.
PMID: 29170666
PMC: 5684122.
DOI: 10.3389/fimmu.2017.01506.
Absolute lymphocyte counts at end of induction correlate with distinct immune cell compartments in pediatric B cell precursor acute lymphoblastic leukemia.
Rolf N, Smolen K, Kariminia A, Velenosi A, Fidanza M, Strahlendorf C
Cancer Immunol Immunother. 2017; 67(2):225-236.
PMID: 29052781
PMC: 11028201.
DOI: 10.1007/s00262-017-2070-3.
Comparison of reference values for immune recovery between event-free patients receiving haploidentical allografts and those receiving human leukocyte antigen-matched sibling donor allografts.
Pei X, Zhao X, Wang Y, Xu L, Zhang X, Liu K
Front Med. 2017; 12(2):153-163.
PMID: 28887808
DOI: 10.1007/s11684-017-0548-1.
Immunological effects of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or philadelphia chromosome-positive acute lymphoblastic leukemia.
Varda-Bloom N, Danylesko I, Shouval R, Eldror S, Lev A, Davidson J
Oncotarget. 2016; 8(1):418-429.
PMID: 27880933
PMC: 5352130.
DOI: 10.18632/oncotarget.13439.
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.
Gea-Banacloche J, Komanduri K, Carpenter P, Paczesny S, Sarantopoulos S, Young J
Biol Blood Marrow Transplant. 2016; 23(6):870-881.
PMID: 27751936
PMC: 5392182.
DOI: 10.1016/j.bbmt.2016.10.001.
Rapid Recovery of CD3+CD8+ T Cells on Day 90 Predicts Superior Survival after Unmanipulated Haploidentical Blood and Marrow Transplantation.
Tian D, Wang Y, Zhang X, Liu K, Huang X, Chang Y
PLoS One. 2016; 11(6):e0156777.
PMID: 27276058
PMC: 4898737.
DOI: 10.1371/journal.pone.0156777.
Dendritic cell reconstitution is associated with relapse-free survival and acute GVHD severity in children after allogeneic stem cell transplantation.
Elze M, Ciocarlie O, Heinze A, Kloess S, Gardlowski T, Esser R
Bone Marrow Transplant. 2014; 50(2):266-73.
PMID: 25387093
DOI: 10.1038/bmt.2014.257.
Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology.
Barker C, Germovsek E, Hoare R, Lestner J, Lewis J, Standing J
Adv Drug Deliv Rev. 2014; 73:127-39.
PMID: 24440429
PMC: 4076844.
DOI: 10.1016/j.addr.2014.01.002.
Use of V(D)J recombination excision circles to identify T- and B-cell defects and to monitor the treatment in primary and acquired immunodeficiencies.
Serana F, Chiarini M, Zanotti C, Sottini A, Bertoli D, Bosio A
J Transl Med. 2013; 11:119.
PMID: 23656963
PMC: 3666889.
DOI: 10.1186/1479-5876-11-119.
Predicting the Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: The Long and Winding Road toward Validated Immune Biomarkers.
Forcina A, Noviello M, Carbone M, Bonini C, Bondanza A
Front Immunol. 2013; 4:71.
PMID: 23531639
PMC: 3607069.
DOI: 10.3389/fimmu.2013.00071.
Early lymphocyte recovery as a predictor of outcome, including relapse, after hematopoietic stem cell transplantation.
Morando J, Fortier S, Pasquini R, Zanis Neto J, Bonfim C
Rev Bras Hematol Hemoter. 2013; 34(6):430-5.
PMID: 23323067
PMC: 3545430.
DOI: 10.5581/1516-8484.20120108.
Adoptive T-cell therapy improves treatment of canine non-Hodgkin lymphoma post chemotherapy.
OConnor C, Sheppard S, Hartline C, Huls H, Johnson M, Palla S
Sci Rep. 2012; 2:249.
PMID: 22355761
PMC: 3278154.
DOI: 10.1038/srep00249.
The impact of early CD4+ lymphocyte recovery on the outcome of patients who undergo allogeneic bone marrow or peripheral blood stem cell transplantation.
Fedele R, Martino M, Garreffa C, Messina G, Console G, Princi D
Blood Transfus. 2012; 10(2):174-80.
PMID: 22337266
PMC: 3320776.
DOI: 10.2450/2012.0034-11.
Immune reconstitution following unmanipulated HLA-mismatched/haploidentical transplantation compared with HLA-identical sibling transplantation.
Chang Y, Zhao X, Huo M, Xu L, Liu D, Liu K
J Clin Immunol. 2011; 32(2):268-80.
PMID: 22173879
DOI: 10.1007/s10875-011-9630-7.